The Effect of Uteroglobin on cPLA2, COX-2 Expression and ERK Activation in NSCLC Cells

비소세포 폐암세포에서 Uteroglobin의 이입에 의한 cPLA2와 COX-2 발현 및 ERK 활성의 변화

  • Kim, Woo Jin (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Yoon, Jung Min (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Lee, Kyoung Hee (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Han, Seon Jin (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Shin, Won Hyuk (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Yim, Jae-Joon (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Yoo, Chul-Gyu (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Lee, Choon Taek (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Han, Sung Koo (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Shim, Young-Soo (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Young Whan (Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine)
  • 김우진 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 윤정민 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 이경희 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 한선진 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 신원혁 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 임재준 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 유철규 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 이춘택 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 한성구 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 심영수 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소) ;
  • 김영환 (서울대학교 의과대학 내과학교실 및 의학연구원 폐연구소)
  • Published : 20040000

Abstract

Background : Uteroglobin is a protein produced by the normal bronchial epithelium and its expression level is lower in non-small cell lung cancer tissues and cell lines. It mainly functions as an anti-inflammatory, and when it is overexpressed in cancer cells, the neoplastic phenotype is antagonized. cPLA2 and COX-2, which are also associated with inflammation, were reported to be related to cancer. The relationship between cPLA2, COX-2 and uteroglobin is unclear. The relationship between uteroglobin and ERK, which is related to cell growth, is also not unclear. This study investigated the changes in the cPLA2 and COX-2 expression levels and the ERK activities after the overexpression of uteroglobin in non-small cell lung cancer cell lines. Methods : The A549 and NCI-H460 cell lines were infected by adenovirus-null and adenovirusuteroglobin. The cChange in the cPLA2, COX-2 expression level and ERK activity after uteroglobin overexpression was measured by Western blot. The change in MMP activity was measured by zymography. Results : Western blot revealed decreased expression levels of cPLA2, and COX-2, and increased pERK levels in nonsmall cell lung cancer cells after uteroglobin overexpression. Zymography revealed no changes in the MMP-2 activity and lower MMP-9 activity. U0126, which is a specific inhibitor of ERK-activating kinase MEK-1/-2, prevented the decrease in the MMP-9 activity Conclusions : A decrease in cPLA2 expression, COX-2 expression, MMP-9 activity and a increase in ERK activity may be related to the anticancer effects of uteroglobin in nonsmall cell lung cancer cells.

연구배경 : Uteroglobin은 정상 폐상피세포에서 발현되는 단백질로 비소세포암 조직이나 세포주에서는 발현이 저하되어있다. 항염증작용을 하며 암세포에 과발현 시키면 암의 형질이 소실됨이 밝혀지고 있다. 역시 염증작용과 관련이 있는 cPLA2와 COX-2도 암과의 관련성이 밝혀지고 있고, 암억제나 MMP의 억제 등의 공통점을 가지고 있으나 이들의 관련성에 대해서는 밝혀진 바가 없다. 또한, COX-2의 암과의 관련성을 설명하는 기전으로 ERK 활성화의 관련 가능성이 있으나, uteroglobin과 ERK의 관련성도 아직 밝혀지지 않고 있다. 비소세포폐암 세포주에 uteroglobin을 과발현시킨 후, cPLA2와 COX-2의 발현, 그리고 MMP-2, MMP-9, ERK의 활성화가 어떻게 변화하는지에 대해 실험하였다. 방 법 : 폐선암세포주인 A549와 NCI-H460 세포주에 adenovirus-uteroglobin, adenovirus-null을 각각 20,100,200 moi로 transduction 시킨 뒤, 48시간 배양한 후에 단백질을 추출하였다. Uteroglobin의 발현을 확인한 후, cPLA2, COX-2, pERK, total ERK에 대해 Western blot을 시행하였고, 배양액으로 zymography를 시행하였다. 결 과 : A549 세포주와 NCI-H460 세포주에서 uteroglobin의 발현을 확인한 세포주에서 cPLA2와 COX-2의 발현이 감소함을 Western blot으로 확인하였고, pERK가 증가함을 Western blot으로 보았고, ERK의 활성화가 증가함을 확인하였다. MMP-9은 활성이 저하되었고, MMP-2는 변화가 없었다. MEK inhibitor인 U0126을 이용하여 ERK의 활성화를 저해시킨 후, uteroglobin의 발현에는 영향이 없었고, MMP-9의 활성저하효과가 소실되었다. 결 론 : 폐암세포주에서 uteroglobin의 항암작용기전에 cPLA2 와 COX-2의 발현의 감소와 ERK의 활성화가 기여할 것으로 사료된다.

Keywords

References

  1. Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S et al. Uteroglobin: a novel cytokine? Cell Mol Life Sci 1999;55:771-87
  2. Linnoila RI, Szabo E, Demayo F, Witschi H, Sabourin C, Malkinson A. The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression. Ann N Y Acad Sci. 2000;923:249-67
  3. Szabo E, Goheer A, Witschi H, Linnoila RI. Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ 1998;9:475-485
  4. Zhang Z, Kundu GC, Panda D, Mandal AK, Mantile-Selvaggi G, Peri A et al. Loss of transformed phenotyped in cancer cells by overexpression of the uteroglobin gene. Proc Natl Acad Sci USA 1999;96:3963-8
  5. Kundu GC, Mandal AK, Zhang Z, Mantile-Selvaggi G, Mukherjee AB. Uteroglobin suppresses extracellular matrix invasion by normal and cancer cels that express the high affinity UG-binding proteins. J Biol Chem 1998;273:22819-24
  6. Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem 1997;272:14501-4
  7. Putten VV, Refaat Z, Dessez C, Blaine S, Wick M, Butterfield L et al. Induction of cytosolic phospholipase A2 by oncogenic Rasia mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem 2001;276:1226-32
  8. Blaine SA, Wick M, Dessez C, Nemenoff RA. Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J Biol Chem 2001;276:42737-43
  9. Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y et al. Increased COX-2 expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 2000;30:73-81
  10. Hasturk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK, Lee JS. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer 2002;94:1023-31
  11. Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T et al. Cyclooxy genase-2 inhibitor induced apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 2000;6:2006-11
  12. Hung W, Chang H, Pan M, Lee T, Chuang L. Induction of p27 as a mechanism underlying NS398 induced growth inhibition in human lung cancer cells. Mol Pharmacol 2000;58:1398-1406
  13. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat Med 2002;3:289-293
  14. JC Lee, KH Park, SJ Han, CG Yoo, CT Lee, SK Han et al. The inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines. Cancer Gene Therapy 2003;10:287-293
  15. Peri A, Bonaccorsi L, Muratori M, Luconi M, Balci E, Granchi S et al. Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. Int J Cancer 2000;88:525-534
  16. Jiang YJ, Hatch GM, Mymin D, Dembinski T, Kroeger EA, Choy PC. Modulation of cytosoloic phospholipase A2 by PPAR activators in human preadipocytes. J Lipid Res 2001;42:716-724
  17. Levy R, Dana R, Hazan I, Levy I, Weber G, Smoilakov R et al. Elevated cytosolic phosphlipase A2 expression and activity in human neutrophils during sepsis. Blood 2000;95:660-5
  18. Niki T, Kohno T, Iba S, Moriya Y, Taka hashi Y, Saito M et al. Frequent co-localization of Cox-2 and laminin-5 $\gamma$2 chain at the invasive front of early-stage lung adonocarcinomas. Am J Pathol 2002;160:1129-41
  19. Tamura M, Sebastian S, Yang S, Gurates B, Ferrer K, Sasano H et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial cells. J Biol Chem 2002;277:26208-16
  20. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-$\alpha$in normal and malignant prostate cells. Cancer Res 2001;61:2720-6
  21. Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M et al. Aspirin and NS-398 inhibit hepatocyte growth factorinduced invasiveness of human hepatoma cells. Hepatology 2002;35:1117-1124
  22. Galve-Roperh I, Sanchez C, Cortes ML, Pulgar TG, Izquierdo M, Guzman M. Antitumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000;6:313-319
  23. Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997;94:448-52
  24. Elder DJ, Halton DE, Playle LC, Paraskeva C. The MEK/ERK pathway mediated COX- 2-selective NSAID-induced apoptosis and in duced COX-2 protein expression in colorectal carcinoma cells. Int J Cancer 2002;99:323-7
  25. Pan MR, Hung WC. Nonsteroidal anti-inflam matory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediaated transcription. J Biol Chem 2002;277:32775-80
  26. Park MJ, Park IC, Lee HC, Woo SH, Lee JY, Hong YJ et al. Protein kinase C-alpha activation by phorbol ester induces secretion of gelatinase B/MMP-9 through ERK 1/2 pathway in capillary endothelial cells. Int J Oncol. 2003;22:137-43